Genetics and epigenetics of NAFLD and NASH: Clinical impact.

By M. Eslam, Luca Valenti, S. Romeo. Journal of Hepatology, 2018

831 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/938ed541e5e38defdd78d1700fc31597d4020a0a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerald I. Shulman
2. S. Friedman
3. R. Loomba
4. D. Clegg
5. B. Palmer

In Endocrinology, Diabetes and Metabolism

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba

In Epidemiology

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba
4. Y. Saiman
5. J. Puche
6. J. Bonner
7. D. Clegg
8. B. Palmer

Citations in the corpus

• Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages (2018, neutral): “Nutritional, genetic, and epigenetic factors each play a role in determining whether an individual with steatosis develops the more severe pathologies of fatty liver disease (Eslam et al., 2018).”
• Mechanisms and disease consequences of nonalcoholic fatty liver disease (2021, background): “Epigenetic alterations have also been implicated in heritability of NAFLD (Eslam et al., 2018; Lee et al., 2017; Stols-Gonçalves et al., 2019), and differences in their expression explain, in part, the higher concordance of risk between monozygotic and dizygotic twins (Zarrinpar et al.”